To check The Effect of Ghrit Madhu Anjana In diabetic Retinopathy patient

Evaluation Of Effect Of Nisha Amalaki Churna With Ghrit-Madhu Anjan In Comparison With Nisha Amalaki Churna In Non-Proliferative Diabetic Retinopathy (Npdr) â?? An Open Labeled Randomised Controlled Clinical Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/06/043067

Enrollment

Registered

2022-06-07

Start date

Unknown

Completion date

Unknown

Last updated

2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H352- Other non-diabetic proliferative retinopathy

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Those who are fit for Anjana Patient having symptoms of Non proliferative diabetic retinopathy. All Patients suffering from Diabetes. Those who give consent, as per requirement. Patient having age between 25 to 70 year

Exclusion criteria

Exclusion criteria: Patients with ocular manifestations due to serious systemic illness like metastatic carcinoma etc. Patient underwent any of the ophthalmic surgeries in past six months. Those contraindicated for Anjana. Autoimmune diseases like Gillian barre syndrome, multiple sclerosis etc. Post cataract Surgery & any other post-operative complication. Patients with contagious diseases like AIDS etc.

Design outcomes

Primary

Measure	Time frame
Prevention of non proliferative diabetic retinopathy into proliferative diabetic retinopathyTimepoint: It Wiil Reduce the Symptoms in 3 Months	—

Secondary

Measure	Time frame
It Wiil Reduce the Symptoms of non proliferative diabetic retinopathy in 3 MonthsTimepoint: Prevention of non proliferative diabetic retinopathy will be on 3 month	—

Countries

India

Contacts

Public ContactDr Manjiri Keskar

parul institute of ayurved

manjirikeskar@gmail.com9822606358

Outcome results